Moderna, Inc. (MRNA)
NASDAQ: MRNA · IEX Real-Time Price · USD
142.55
-8.94 (-5.90%)
At close: May 31, 2024, 4:00 PM
142.97
+0.42 (0.29%)
After-hours: May 31, 2024, 7:59 PM EDT
Moderna Stock Forecast
Stock Price Forecast
The 14 analysts with 12-month price forecasts for Moderna stock have an average target of 131.57, with a low estimate of 86 and a high estimate of 231. The average target predicts a decrease of -7.70% from the current stock price of 142.55.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Moderna stock from 17 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 3 | 3 | 4 | 4 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 9 | 9 | 7 | 8 | 8 | 8 |
| Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 18 | 17 | 15 | 16 | 17 | 17 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Evercore ISI Group | Evercore ISI Group | Hold Initiates $120 | Hold | Initiates | $120 | -15.82% | May 14, 2024 |
| UBS | UBS | Strong Buy Maintains $143 → $151 | Strong Buy | Maintains | $143 → $151 | +5.93% | May 7, 2024 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $91 → $106 | Hold | Maintains | $91 → $106 | -25.64% | May 3, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $125 → $135 | Buy | Maintains | $125 → $135 | -5.30% | May 3, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $142 → $163 | Buy | Maintains | $142 → $163 | +14.35% | May 3, 2024 |
Financial Forecast
Revenue This Year
4.24B
from 6.85B
Decreased by -38.13%
Revenue Next Year
4.82B
from 4.24B
Increased by 13.76%
EPS This Year
-7.29
from -12.33
EPS Next Year
-5.39
from -7.29
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 4.9B | 6.2B | 10.1B | 22.1B | 40.6B |
| Avg | 4.2B | 4.8B | 6.3B | 8.8B | 14.7B |
| Low | 3.5B | 3.5B | 3.5B | 3.3B | 6.1B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -28.6% | 46.2% | 109.9% | 251.8% | 363.0% |
| Avg | -38.1% | 13.8% | 30.6% | 39.3% | 67.6% |
| Low | -48.6% | -17.4% | -27.0% | -48.2% | -30.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -6.36 | -1.04 | 13.62 | 17.96 | 40.11 |
| Avg | -7.29 | -5.39 | -1.63 | 3.51 | 14.04 |
| Low | -8.35 | -7.06 | -6.71 | -3.38 | 2.28 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 1,042.4% |
| Avg | - | - | - | - | 299.8% |
| Low | - | - | - | - | -35.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.